BN Business News
Add your company to Business Communicator →

Regulation & law · 06/10/2021

National Cancer Institute to Grant Exclusive Patent License to NE1 Inc for Cancer Immunotherapy

The National Cancer Institute is considering granting an exclusive patent license to NE1 Inc to use a personalized tumor vaccine for cancer immunotherapy, based on U.S. patents and patent applications.

Original source language: Federal Register — All DocumentsOpen original release →

Explore insights